On 14 November 2016
Concord Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2016, to approve the Un - Audited financial results for the quarter ended 30 September 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content